120 related articles for article (PubMed ID: 38307557)
1. Reappraisal of a Renovated Cell-free and Concentrated Ascites Reinfusion Therapy for Malignant Ascites.
Kim Y; Ajiki T; Ueda Y; Yoshida Y; Takahashi T; Fukuyama H; Fukuyama T; Hori Y
Anticancer Res; 2024 Feb; 44(2):613-619. PubMed ID: 38307557
[TBL] [Abstract][Full Text] [Related]
2. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of cell-free and concentrated ascites reinfusion therapy in the therapeutic management of advanced ovarian cancer patients with massive ascites.
Kawata Y; Nagasaka K; Matsumoto Y; Oda K; Tanikawa M; Sone K; Mori-Uchino M; Tsuruga T; Arimoto T; Osuga Y; Fujii T
Int J Clin Oncol; 2019 Apr; 24(4):420-427. PubMed ID: 30474762
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of Patients and Their Ascites Who Underwent Repeated Cell-Free and Concentrated Ascites Reinfusion Therapy.
Maeda S; Yabuuchi J; Nobuta H; Makiishi T; Hirose K
Ther Apher Dial; 2015 Aug; 19(4):342-8. PubMed ID: 26386222
[TBL] [Abstract][Full Text] [Related]
5. [Breast Cancer with Cancerous Ascites with Good QOL by KM-CART-A Case Report].
Iimori N; Nishimura S; Kushitani Y; Tokumoto M; Taenaka N; Terashima K
Gan To Kagaku Ryoho; 2020 Dec; 47(13):1983-1985. PubMed ID: 33468774
[TBL] [Abstract][Full Text] [Related]
6. Quality of life assessment of cell-free and concentrated ascites reinfusion therapy during initial treatment for advanced ovarian cancer: A prospective cohort study.
Yamamoto K; Nagao S; Tsu T; Matsushima T; Ishido Y; Narita M; Suzuki K; Nakazawa H; Shibutani T; Jimi T; Yano H; Kitai M; Shiozaki T; Matsuoka K; Yamaguchi S
J Obstet Gynaecol Res; 2021 Apr; 47(4):1536-1543. PubMed ID: 33469981
[TBL] [Abstract][Full Text] [Related]
7. Improvement of Major Problems in the Cell-Free and Concentrated Ascites Reinfusion Therapy System─Constructing of Cell-Free and Concentrated Ascites Reinfusion Therapy System Using External Pressure for Filtration.
Yoshizawa M; Nakatsuji Y
Ther Apher Dial; 2019 Jun; 23(3):233-236. PubMed ID: 31033153
[TBL] [Abstract][Full Text] [Related]
8. [A New Treatment Strategy-Novel Cell-Free and Concentrated Ascites Reinfusion System(KM-CART)for Massive Malignant Ascites].
Matsusaki K
Gan To Kagaku Ryoho; 2016 Dec; 43(13):2490-2497. PubMed ID: 28028255
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in gastrointestinal cancer patients with massive ascites treated with systemic chemotherapy.
Nagata Y; Kato K; Miyamoto T; Hirano H; Shoji H; Iwasa S; Honma Y; Takashima A; Hamaguchi T; Matsushita H; Nagashima K; Saruta M; Boku N
Support Care Cancer; 2020 Dec; 28(12):5861-5869. PubMed ID: 32253601
[TBL] [Abstract][Full Text] [Related]
10. [Cell-Free Ascites Reinfusion Therapy(CART)Modified by Keisuke Matsusaki(KM-CART)at Our Hospital].
Iwaki R; Shindo K; Kawahara H; Nanba N; Kuramoto Y; Beppu T; Uesugi T; Tanaka Y; Uesugi Y
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2165-2167. PubMed ID: 30692319
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites.
Yokomichi N; Imai K; Sakamoto M; Horiki M; Yamauchi T; Miwa S; Inoue S; Uneno Y; Suzuki H; Wada T; Ichikawa Y; Morita T
BMC Cancer; 2022 Feb; 22(1):218. PubMed ID: 35227250
[TBL] [Abstract][Full Text] [Related]
12. Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience.
Tsubokura M; Adegawa Y; Kojima M; Tanosaki R; Ohtake R; Kase Y; Iwashita N; Kasane M; Nakabayashi S; Takeuchi S; Kato K; Boku N; Kanemitsu Y; Okusaka T; Fujimoto H; Yonemori K; Ishiki H; Kawamura K; Satomi E; Matsushita H
BMC Cancer; 2022 Mar; 22(1):268. PubMed ID: 35287609
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of reinfusion of concentrated ascitic fluid for malignant ascites: a concept-proof study.
Hanada R; Yokomichi N; Kato C; Miki K; Oyama S; Morita T; Kawahara R
Support Care Cancer; 2018 May; 26(5):1489-1497. PubMed ID: 29168037
[TBL] [Abstract][Full Text] [Related]
14. Ascitic IL-10 Concentration Predicts Prognosis of Patients Undergoing Cell-Free and Concentrated Ascites Reinfusion Therapy.
Ito T; Hanafusa N; Iwase S; Noiri E; Nangaku M; Nakagawa K; Miyagawa K
Ther Apher Dial; 2020 Feb; 24(1):90-95. PubMed ID: 31157953
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of cell-free and concentrated ascites reinfusion therapy against cirrhotic ascites in comparison with malignancy-related ascites.
Ito T; Hanafusa N; Soneda N; Isoai A; Kobayashi R; Torii N; Kato M
J Gastroenterol Hepatol; 2021 Nov; 36(11):3224-3232. PubMed ID: 34250635
[TBL] [Abstract][Full Text] [Related]
16. Safety of repeated cell-free and concentrated ascites reinfusion therapy for malignant ascites from gastrointestinal cancer.
Maeda O; Ando T; Ishiguro K; Watanabe O; Miyahara R; Nakamura M; Funasaka K; Kazuhiro F; Ando Y; Goto H
Mol Clin Oncol; 2014 Nov; 2(6):1103-1106. PubMed ID: 25279205
[TBL] [Abstract][Full Text] [Related]
17. A Method for Stabilizing the Proportion of the Reduced Form of Albumin During Cell-Free and Concentrated Ascites Reinfusion Therapy in Patients with Malignant Ascites.
Ohashi A; Nakai S; Yamada S; Kato M; Hasegawa M
Ther Apher Dial; 2019 Jun; 23(3):242-247. PubMed ID: 31033167
[TBL] [Abstract][Full Text] [Related]
18. CART: Cell-free and Concentrated Ascites Reinfusion Therapy against malignancy-related ascites.
Ito T; Hanafusa N
Transfus Apher Sci; 2017 Oct; 56(5):703-707. PubMed ID: 28916401
[TBL] [Abstract][Full Text] [Related]
19. Concentrated ascites reinfusion therapy for sinusoidal obstructive syndrome after hematopoietic stem cell transplantation.
Takahashi H; Sakai R; Fujita A; Kuwabara H; Hattori Y; Matsuura S; Ohshima R; Hagihara M; Tomita N; Ishigatsubo Y; Fujisawa S
Artif Organs; 2013 Oct; 37(10):932-6. PubMed ID: 23692354
[TBL] [Abstract][Full Text] [Related]
20. Effects of cell-free and concentrated ascites reinfusion therapy (CART) on symptom relief of malignancy-related ascites.
Ito T; Hanafusa N; Iwase S; Noiri E; Nangaku M; Nakagawa K; Miyagawa K
Int J Clin Oncol; 2015 Jun; 20(3):623-8. PubMed ID: 25239690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
